A universal method to analyze cellular internalization mechanisms via endocytosis without non‐specific cross‐effects. Issue 2 (9th January 2023)

• Record Type: Journal Article
• Authors: Itagaki, Mai; Nasu, Yoshinori; Sugiyama, Chiaki; Nakase, Ikuhiko; Kamei, Noriyasu
• Is Part Of: FASEB journal. Volume 37:Issue 2(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2023-01-09
• Subjects: cellular internalization -- drug delivery system -- endocytosis -- inhibitor -- siRNA; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202201780R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Endocytosis is an essential biological process for nutrient absorption and intercellular communication; it can also be used to accelerate the cellular internalization of drug delivery carriers. Clarifying the cellular uptake mechanisms of unidentified endogenous and exogenous molecules and designing new effective drug delivery systems require an accurate, specific endocytosis analysis methodology. Therefore, we developed a method to specifically evaluate cellular internalization via three main endocytic pathways: clathrin‐ and caveolae‐mediated endocytosis, and macropinocytosis. We first revealed that most known endocytosis inhibitors had no specific inhibitory effect or were cytotoxic. Second, we successfully established an alternative method using small interfering RNA to knock down dynamin‐2 and caveolin‐1, which are necessary for clathrin‐ and caveolae‐mediated endocytosis, in HeLa cells. Third, we established another method to specifically analyze macropinocytosis using rottlerin on A431 cells. Finally, we validated the proposed methods by testing the cellular internalization of a biological molecule (insulin) and carriers (nanoparticles and cell‐penetrating peptides). Through this study, we established versatile methods to precisely and specifically evaluate endocytosis of newly developed biopharmaceuticals or drug delivery systems.